Drug intelligence / Profile preview

T4N5 endonuclease liposome

Development stage
Preclinical
Lead developer
Chongqing Fujin Biomedical
Modality
Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
Administration
Topical
01

Overview

T4N5 Endonuclease Liposome is a topical liposomal formulation of the recombinant bacterial DNA repair enzyme T4 endonuclease V (T4N5), currently in preclinical development by Chongqing Fujin Biomedical. T4N5 endonuclease specifically recognizes and initiates the repair of ultraviolet (UV)-induced cyclobutane pyrimidine dimers (CPDs) in DNA, which are major drivers of mutagenesis, photoaging, and skin cancers. By encapsulating the hydrophilic and high-molecular-weight T4N5 enzyme in pH-sensitive liposomes, the formulation enhances penetration through the stratum corneum to deliver the active enzyme directly into the nuclei of epidermal cells. Chongqing Fujin Biomedical is developing this topical enzyme therapy for the treatment and prevention of xeroderma pigmentosum, photoaging, photo-damaged skin, and post-organ-transplant photosensitivity.

Brand names
DimericineLipoT4N5LipoT-4N5LipoT 4N5
Other names
T4 endonuclease V liposomeT-4 endonuclease V liposomeT 4 endonuclease V liposomeT4N5 endonuclease liposomeT-4N5 endonuclease liposomeT 4N5 endonuclease liposomeT4N5 endonuclease topical formulationT-4N5 endonuclease topical formulationT 4N5 endonuclease topical formulationT4N5 liposomal lotionT-4N5 liposomal lotionT 4N5 liposomal lotionT4N5 liposomeT-4N5 liposomeT 4N5 liposome

Beyond the preview

Go deeper on T4N5 endonuclease liposome.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T4N5 endonuclease liposome.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call